BRD7-IN-3 (compound 1-78) functions as a dual inhibitor targeting the bromodomain-containing proteins BRD7 and BRD9, demonstrating half-maximal inhibitory concentrations (IC50s) of 1.6 µM for BRD7 and 2.7 µM for BRD9, respectively [1].
Molecular Weight:
294.35
Formula:
C18H18N2O2
Target:
Epigenetic Reader Domain
* VAT and and shipping costs not included. Errors and price changes excepted
